Aa
A
A
Close
Avatar universal
Post liver transplant antiviral management
I have a question: post liver transplant patient on Baraclude and finishing the IGHB infusion was adviced to switch on Truvada as antiviral agent instead of Baraclude and finishing the infusion sesions. Can somebody tell me if this is a better choice of managing the post liver transplant patient?
Cancel
1 Answers
Page 1 of 1
Avatar universal

if liver transplant is managed at best and hbsg/hbvdna was not high hbsag should b negative now

truvada is a very bad option because it damages kidneys

IGHB infusion is expensive so insurance companies try to stop it but it must not be stopped, in italy it is free and it is never stopped becuase it is the most important to avoid any possibility of hbsag positive to come back

entecavir is ok as long as hbsag is negative and hbig is kept
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Comment
Post Comment
Your Answer
Avatar universal
Answer
Do you know how to answer? Tap here to leave your answer...
Answer
Answer
Post Answer
A
A
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis B Community Resources